Mie University · University Hospital · 准教授

Research keywordspulmonary hypertension・BMPR2・congenital heart disease・fetal growth restriction・tadalafil therapy・perinatal hypoxia・pediatric cardiology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• 50. Tsuji M, Maki S, Enomoto N, Okamoto K, Kitamura A, Magawa S, Takakura S, Nii M, Tanaka K, Yodoya N, Tanaka H, Sawada H, Kondo E, Hirayama M, Ikeda T. Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction. Medicina (Kaunas). 2023 May 8;59(5):900. doi: 10.3390/medicina59050900. PMID: 37241131; PMCID: PMC10223650.2023 · 主な業績等
• 48. Kabwe JC; Sawada H; Mitani Y; Oshita H; Tsuboya N; Zhang E; Maruyama J; Miyasaka Y; Ko H; Oya K; Ito H; Yodoya N; Otsuki S; Ohashi H; Okamoto R; Dohi K; Nishimura Y; Mashimo T; Hirayama M; Maruyama K. CRISPR-Mediated Bmpr2 Point Mutation Exacerbates Late Pulmonary Vasculopathy and Reduces Survival in Rats with Experimental Pulmonary Hypertension. Respir Res. 2022 Apr 8;23(1):87.2022 · 主な業績等
• 49. Oshita H, Sawada H, Mitani Y, Tsuboya N, Kabwe JC, Maruyama J, Yusuf A, Ito H, Okamoto R, Otsuki S, Yodoya N, Ohashi H, Oya K, Kobayashi Y, Kobayashi I, Dohi K, Nishimura Y, Saitoh S, Maruyama K, Hirayama M. Perinatal hypoxia aggravates occlusive pulmonary vasculopathy in SU5416/hypoxia-treated rats later in life. Am J Physiol Lung Cell Mol Physiol. 2022 Aug 1;323(2):L178-L192. doi: 10.1152/ajplung.00422.2021. Epub 2022 Jun 28. PMID: 35762603.2022 · 主な業績等
• 46. Kawai M, Zhang E, Kabwe JC, Okada A, Maruyama J, Sawada H, Maruyama K. Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension. BMC Pulm Med. 2022 Mar 5;22(1):78. doi: 10.1186/s12890-022-01867-62022 · 主な業績等

• 実験的肺高血圧に対する亜硝酸依存性ＮＯ合成機構の賦活による治療
• Deep Learningを活用した超音波ガイドによる安全な静脈穿刺法の開発
• 周産期侵襲による実験的肺高血圧の薬物療法の開発と病態解明：DOHaD仮説の応用
• 肺動脈性肺高血圧の血管病変形成への血管平滑筋と炎症の関与 ：ゲノム編集技術の応用

• Official profile
• ORCID